Article
Cerebrotendinous xanthomatosis: a family study of sterol 27-hydroxylase mutations and pharmacotherapy.
QJM : monthly journal of the Association of Physicians - 1 Jan 1996
Watts G F, Mitchell W D, Bending J J, Reshef A, Leitersdorf E
Abstract excerpt
We examined the phenotypic characteristics, molecular genetics and optimal pharmacological treatment of cerebrotendinous xanthomatosis (CTX) in an English family with combined hyperlipidaemia. The proband presented in adulthood with classical clinical characteristics of CTX, a greater than tenfold elevation in plasma cholestanol and combined hyperlipidaemia. His brother also had typical features of CTX without...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
